mTOR pathway and mTOR inhibitors as agents for cancer therapy. [electronic resource]
- Current cancer drug targets Dec 2008
- 647-65 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1873-5576
10.2174/156800908786733513 doi
Animals Antineoplastic Agents--pharmacology Drug Design Humans Neoplasms--drug therapy Protein Kinases--drug effects Signal Transduction--drug effects TOR Serine-Threonine Kinases